Download PDF
Thromb Haemost 1966; 15(03/04): 365-380
DOI: 10.1055/s-0038-1649438
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Effect of Alkaline and Acid Phosphatases on Clotting:

Evidence that Alkaline Phosphatase Enhances Activation of Factor IX by SF, and that Acid Phosphatase Enhances Plasmatic Anti-SF[*]
P. G Iatridis
1   Department of Physiology, University of North Carolina School of Medicine, Chapel Hill, N. G
,
J. H Ferguson
1   Department of Physiology, University of North Carolina School of Medicine, Chapel Hill, N. G
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

Also available at
   Permissions and Reprints

Summary

Alkaline phosphatase is found to enhance the activation of factor IX by SF. The correlation of the distribution of alkaline phosphatase in electrophoretic fractions with the clotting tests suggest that the “beta” fraction contains the responsible factor for the acceleratory effect of alkaline phosphatase on clotting.

Acid phosphatase, while not exerting a direct inhibitory effect on SF, does enhance the plasmatic anti-SF activity. The “beta” and “F-gamma” fractions seem to contain the responsible factor of acid phosphatase for the plasmatic anti-SF enhancement.

SF preparation has no acid or alkaline phosphatase activity.

A tentative schema is proposed to explain the effects of acid and alkaline phosphatase on clotting.

* This study was aided by USPHS Research Grant No. HE01510-12.


 

  • References

  • 1 Ferguson J. H. Blood and body functions. F. A. Davis Co; Philadelphia: 1965
    Search in Google Scholar
  • 2 Macfarlane R. G, Biggs R, Ash B. J, Denson K. W. E. The interaction of factors VIII and IX. Brit. J. Haemat 10: 530 1964;
    CrossrefPubMedSearch in Google Scholar
  • 3 Davie E. W, Ratnoff O. D. Waterfall sequence for intrinsic blood clotting. Science 145: 1310 1964;
    CrossrefPubMedSearch in Google Scholar
  • 4 Ferguson J. H, Erickson B. N. The coagulant action of crystalline trypsin, cephalin, and lung extracts. Amer. J. Physiol 126: 661 1939;
    PubMedSearch in Google Scholar
  • 5 Ferguson J. H. A new blood clotting theory. Science 97: 319 1943;
    CrossrefPubMedSearch in Google Scholar
  • 6 Seegers W. H. Prothrombin. Harvard Univ. Press; Cambridge, Mass: 1962
  • 7 Ferguson J. H. Thromboplastic enzymes. Fed. Proc 23: 762 1964;
    PubMedSearch in Google Scholar
  • 8 Alexander B. Some biochemical, physiochemical and immunochemical studies of prothrombin and proconvertin (factor VII): Their biopathologic significance. Proc. 4th Internat. Congr. Biochem. 1959
    PubMedSearch in Google Scholar
  • 9 Kazal L. A. Interaction of phospholipids with lipoproteins, with serum and its protein, and with proteolytic and nonproteolytic enzymes in blood clotting. Trans. N.Y. Acad. Sci 27: 613 1965;
    CrossrefPubMedSearch in Google Scholar
  • 10 Iatridis P. G, Ferguson J. H. ATP-ase as an in vitro inhibitor of surface factor in the blood-clotting mechanism. Proc. Soc. exp. Biol. (N.Y.) 118: 647 1965;
    CrossrefPubMedSearch in Google Scholar
  • 11 Bettex-Galland M, Lüscher E. F. Thrombosthenin a contractile protein from thrombocytes. Its extraction from human blood platelets and some of its properties. Biochim. biophys. Acta (Amst.) 49: 536 1961;
    CrossrefPubMedSearch in Google Scholar
  • 12 Iatridis P. G, Ferguson J. H. The plasmatic atmosphere of blood platelets. Evidence that only fibrinogen, AcG, and activated Hageman factor are present on the surface of platelets. Thrombos. Diathes. haemorrh. (Stuttg.) 13: 114 1964;
    PubMedSearch in Google Scholar
  • 13 Marcus A. J, Zucker M. B. The physiology of blood platelets: Recent Biochemical, Morphologic, and clinical research. Grune and Stratton; N.Y: 1965
  • 14 Iatridis S. G, Ferguson J. H, Iatridis P. G, Mauldin R. Thrombogenic properties of surface factor: Evidence for an anti-surface factor activity in canine plasma. Thrombos. Diathes. haemorrh. (Stuttg.) 12: 35 1964;
    PubMedSearch in Google Scholar
  • 15 Iatridis S. G, Ferguson J. H. Active Hageman factor: a plasma lysoldnase of the human fibrinolytic system. J. clin. Invest 41: 1277 1962;
    CrossrefPubMedSearch in Google Scholar
  • 16 Iatridis S. G, Ferguson J. H. A two stage assay method for Hageman factor activity. Thrombos. Diathes. haemorrh. (Stuttg.) 08: 46 1962;
    PubMedSearch in Google Scholar
  • 17 Iatridis S. G, Iatridis P. G, Ferguson J. H. Roles of surface factor and a plasma inhibitory activity (Anti-SF) during experimental thrombosis in rabbits. Thrombos. Diathes. haemorrh. (Stuttg.) 12: 489 1964;
    PubMedSearch in Google Scholar
  • 18 Langdeil R. D, Wagner R. H, Brinkhous K. M. Effect of antihemophilic factor on one- stage clotting tests. A presumptive test for hemophilia and a simple one-stage antihemophilic factor assay procedure. J. Lab. clin. Med 41: 637 1953;
    PubMedSearch in Google Scholar
  • 19 Nye S. W, Graham J. B, Brinkhous K. M. The partial thromboplastic time as a screening test for the detection of latent bleeders. Amer. J. med. Sci 243: 55-279 1962;
    CrossrefPubMedSearch in Google Scholar
  • 20 Bell W. N, Alton H. G. A brain extract as substitute for platelet suspensions in the thromboplastin generation test. Nature (Lond.) 174: 880 1954;
    CrossrefPubMedSearch in Google Scholar
  • 21 Bessey O. H, Lowry O. H, Brock M. J. A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J. biol. Chem 164: 321 1946;
    PubMedSearch in Google Scholar
  • 22 Andersch M. A, Szczypinski A. J. Use of p-nitrophenylphosphate as the substrate in determination of serum acid phosphatase. Amer. J. clin. Path 17: 571 1947;
    PubMedSearch in Google Scholar
  • 23 Korner N. H. Distribution of alkaline phosphatase in serum protein fractions. J. clin. Path 15: 195 1962;
    CrossrefPubMedSearch in Google Scholar
  • 24 Nossel H. L. The contact phase of blood coagulation. F. A. Davis & Co; Philadelphia: 1964
    Search in Google Scholar
  • 25 Dubbs G. A, Vivonia G, Hilburn J. H. Subfractionation of human serum enzymes. Science 131: 1529 1960;
    CrossrefPubMedSearch in Google Scholar
  • 26 de Grouchy J. Répartition des activités estérasiques et phosphatasiques du sérum humain par rapport aux séro-proteines actuellement connues. Rev. franç. Étud. clin. biol 03: 881 1958;
    PubMedSearch in Google Scholar
  • 27 Thomas D. P, Wessler S, Reimer S. M. The relation of factors XII, XI, and IX to hypercoagulable states. Thrombos. Diathes. haemorrh. (Stuttg.) 09: 90 1963;
    PubMedSearch in Google Scholar